Inova Announces Gift to Endow Sheridan Director, Molecular Tumor Board at Inova Schar Cancer Institute

Falls Church, VA —Inova today announced that it has received a $1 million gift from Win Sheridan, co-founder of APEX Systems, to endow the role of the Director of the Molecular Tumor Board at Inova Schar Cancer Institute. In recognition of Sheridan’s generous gift, this position will be renamed to be the Sheridan Director, Molecular…

Read More

Proton Therapy for Pediatric Patients

Cancer is a formidable diagnosis, but it is even more disconcerting when it affects a child. Radiation, a traditional therapy to treat the disease, can harm a child’s growing body, resulting in developmental delays, hormone deficiencies, and restricted bone growth. Many of the pediatric patients also experience a long-term side effect from this therapy, including…

Read More

Direct-to-Consumer Genetic Testing for Inherited Cancer Risk

Morgan Turner, MS, CGC, is a Virginia-licensed and nationally board-certified, cancer-specialized genetic counselor at Inova Schar Cancer Institute. She joined Inova in June 2018. Many patients are surprised to learn that the majority of people who are diagnosed with a cancer do not have a genetic (or inherited) cause for their cancer. Indeed, it is…

Read More

Healthy Summer Nutrition Tips

Lauren Fay, RD, CSO, CNSC, is a registered dietitian at the Inova Schar Cancer Institute and Life With Cancer. She is board-certified in oncology nutrition and nutrition support. Summer is well underway, and with the warmer temperatures (and the ability to spend time in larger groups of our vaccinated family and friends) many of us…

Read More

Early Study Finds MGC018 Active in Resistant Skin Cancer

Sekwon Jang, MD in medical oncology at Inova Schar Cancer Institute, presented the latest data on the multi-institutional Phase 1 clinical trial for MGC018 at the annual American Society of Clinical Oncology held June 4–8, 2021. What is MGC018? MGC018 is an investigational drug developed by MacroGenics that is being studied for the treatment of…

Read More

Pancreatic Cancer Prevention and Warning Signs

Jennifer L. Gnerlich, MD, FACS, FSSO is a specialty care physician in general surgery and complex general surgical oncology at Inova Schar Cancer Institute. She specializes in upper Gastrointestinal (GI) cancers and carcinomatosis. With the recent deaths of Ruth Bader Ginsburg and Alex Trebek, more people want to know about pancreatic cancer. While not a…

Read More

Colorectal Cancer Screening Should Begin at Age 45

Arthur Winer, MD, is a specialty care physician at Inova Schar Cancer Institute. Dr. Winer is board-certified in internal medicine, hematology and medical oncology. He is a practicing gastrointestinal medical oncologist and has clinical interests in colorectal, esophageal, gastrointestinal, liver and pancreatic cancers. For decades, experts advised people to begin colorectal cancer screening at age…

Read More

Is Radiation Necessary After Breast Cancer Surgery?

doctor comforting a patient

Ductal carcinoma in situ (DCIS) is a cancer that forms in the cells that line the milk ducts, and it accounts for 20% of new breast cancer diagnoses. The most common treatment is breast-conserving surgery to remove the cancerous tissue. While only a small percentage of women experience an invasive cancer event following surgery, radiation…

Read More

Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study

person using a stylus on a tablet

The COVID-19 pandemic has spurred cancer teams to find new ways to care safely for patients with cancer, in particular outpatients who have tested positive for COVID-19 but do not require hospitalization. Inova Schar Cancer Institute’s physicians and advanced practice providers utilized a program called remote patient monitoring (RPM) to observe COVID-positive outpatients. To study…

Read More